https://oncdata.com/ daily 1.0 https://oncdata.com/blog daily 0.9 https://oncdata.com/news daily 0.9 https://oncdata.com/contact monthly 0.4 https://oncdata.com/videos weekly 0.6 https://oncdata.com/glp-1-receptor-agonists-in-breast-cancer 2026-10-15 monthly 0.7 https://oncdata.com/operationalizing-quality-frameworks-in-oncology-real-world-data 2026-10-08 monthly 0.7 https://oncdata.com/new-milestone-for-ai-powered-cancer-vaccine 2026-10-06 monthly 0.7 https://oncdata.com/reimagining-oncology-education-with-ai 2026-10-01 monthly 0.7 https://oncdata.com/bringing-bispecific-antibodies-into-community-myeloma-care 2026-09-22 monthly 0.7 https://oncdata.com/beyond-the-headlines-ai-in-breast-oncology 2026-09-15 monthly 0.7 https://oncdata.com/personalizing-surgical-risk-assessment-in-lung-cancer 2026-09-10 monthly 0.7 https://oncdata.com/oncology-unfiltered-clinical-trial-enrollment-barriers 2026-09-03 monthly 0.7 https://oncdata.com/simulation-modeling-reducing-oncology-clinic-wait-times 2026-08-25 monthly 0.7 https://oncdata.com/making-the-match-how-ai-improves-clinical-trial-matching 2026-08-21 monthly 0.7 https://oncdata.com/new-paths-forward-in-cutaneous-t-cell-lymphoma 2026-08-18 monthly 0.7 https://oncdata.com/real-world-evidence-ai-in-oncology 2026-08-11 monthly 0.7 https://oncdata.com/oncology-unfiltered-immunotherapy-fatigue 2026-08-06 monthly 0.7 https://oncdata.com/prostate-cancer-faculty-follow-up 2026-07-29 monthly 0.7 https://oncdata.com/additional-advances-ep-necs 2026-07-23 monthly 0.7 https://oncdata.com/earlier-detection-better-outcomes-ovarian-cancer 2026-07-16 monthly 0.7 https://oncdata.com/tailoring-diagnostic-treatment-strategies-systemic-mastocytosis 2026-07-13 monthly 0.7 https://oncdata.com/information-overload-and-the-portal-patient 2026-07-09 monthly 0.7 https://oncdata.com/how-a-multi-llm-ensemble-accelerates-drug-repurposing 2026-07-06 monthly 0.7 https://oncdata.com/personalizing-cancer-prevention-ai-enhanced-imaging 2026-07-01 monthly 0.7 https://oncdata.com/silent-side-effect-ototoxicity-germ-cell-tumor-treatment 2026-06-29 monthly 0.7 https://oncdata.com/equity-preventive-oncology-identity-anatomy 2026-06-25 monthly 0.7 https://oncdata.com/racial-ethnic-representation-oncology-clinical-trials 2026-06-24 monthly 0.7 https://oncdata.com/from-curiosity-to-contribution-how-oncologists-can-engage-in-ai-and-innovation 2026-06-23 monthly 0.7 https://oncdata.com/ndmm-live-virtual-rounds-preview 2026-06-22 monthly 0.7 https://oncdata.com/lgbtq-health-equity-lessons-from-a-three-time-survivor 2026-06-22 monthly 0.7 https://oncdata.com/no-one-is-invincible-proactive-skin-cancer-screening 2026-06-17 monthly 0.7 https://oncdata.com/partners-in-care-community-mens-health 2026-06-16 monthly 0.7 https://oncdata.com/asco-voices-patient-trust 2026-06-12 monthly 0.7 https://oncdata.com/human-expertise-matters-age-of-ai 2026-06-11 monthly 0.7 https://oncdata.com/new-door-in-lung-cancer-targeting-met-amplification 2026-06-10 monthly 0.7 https://oncdata.com/can-podcasts-help-improve-adoption-of-her2-low-therapies 2026-06-09 monthly 0.7 https://oncdata.com/national-cancer-survivors-day-2026 2026-06-05 monthly 0.7 https://oncdata.com/oncology-unfiltered-tumor-board-vs-tuesday-afternoon 2026-06-04 monthly 0.7 https://oncdata.com/debunking-myths-in-breast-cancer-screening 2026-06-02 monthly 0.7 https://oncdata.com/targeting-ras-in-pancreatic-cancer-emerging-clinical-evidence-and-the-promise-of-next-generation-inhibitors 2026-06-01 monthly 0.7 https://oncdata.com/strength-in-community-alix-shulman 2026-06-01 monthly 0.7 https://oncdata.com/can-exercise-lower-lung-cancer-risk 2026-05-29 monthly 0.7 https://oncdata.com/mental-health-awareness-month-2026 2026-05-28 monthly 0.7 https://oncdata.com/melanoma-matters-recognizing-risk-acting-early-and-advancing-care 2026-05-12 monthly 0.7 https://oncdata.com/vepdegestrant-approved-for-her2-negative-advanced-or-metastatic-breast-cancer 2026-05-11 monthly 0.7 https://oncdata.com/oncology-unfiltered-the-real-world-vs-the-trial-patient 2026-05-07 monthly 0.7 https://oncdata.com/ai-driven-pathological-subtyping-pancreatic-cancer-ashish-manne 2026-05-04 monthly 0.7 https://oncdata.com/asco-gu-2026 2026-04-29 monthly 0.7 https://oncdata.com/patient-experience-week 2026-04-27 monthly 0.7 https://oncdata.com/clinical-trial-representation-cha-friedson 2026-04-23 monthly 0.7 https://oncdata.com/egg-and-embryo-cryopreservation-meaghan-delaney 2026-04-20 monthly 0.7 https://oncdata.com/national-minority-health-month-2026 2026-04-16 monthly 0.7 https://oncdata.com/exploring-ai-helioliver 2026-04-15 monthly 0.7 https://oncdata.com/power-of-community-for-women-in-science-and-research 2026-04-13 monthly 0.7 https://oncdata.com/exercise-for-older-cancer-survivors-dispelling-the-myths-and-creating-guidance-with-kerri-winters-stone-phd 2026-04-09 monthly 0.7 https://oncdata.com/aya-cancer-awareness-addressing-biological-distinctiveness-survivorship-and-the-whole-person-approach 2026-04-07 monthly 0.7 https://oncdata.com/additional-advances-in-esophagogastric-cancer-research-and-clinical-trials 2026-04-06 monthly 0.7 https://oncdata.com/her2-mutant-nsclc-zongertinib-approval 2026-04-03 monthly 0.7 https://oncdata.com/oncology-unfiltered-choosing-not-to-treat 2026-04-02 monthly 0.7 https://oncdata.com/mrd-complete-response-end-points-banerjee-richardson 2026-03-31 monthly 0.7 https://oncdata.com/national-doctors-day-2026 2026-03-30 monthly 0.7 https://oncdata.com/hemophilia-additional-advances-sidonio 2026-03-27 monthly 0.7 https://oncdata.com/perioperative-chemoimmunotherapy-nsclc-meir-aung 2026-03-26 monthly 0.7 https://oncdata.com/nivolumab-plus-chemotherapy-approved-for-previously-untreated-hodgkin-lymphoma 2026-03-25 monthly 0.7 https://oncdata.com/the-octavia-problem-optimizing-cancer-care-in-the-era-of-ai 2026-03-20 monthly 0.7 https://oncdata.com/national-nutrition-month-2026 2026-03-18 monthly 0.7 https://oncdata.com/inav-daniel-king 2026-03-16 monthly 0.7 https://oncdata.com/neuroendocrine-tumor-additional-advances 2026-03-11 monthly 0.7 https://oncdata.com/teclistamab-approved-for-relapsed-or-refractory-multiple-myeloma 2026-03-09 monthly 0.7 https://oncdata.com/international-womens-day-sharing-knowledge-and-community-with-jasmin-hundal-and-megan-claire-chase 2026-03-09 monthly 0.7 https://oncdata.com/oncology-unfiltered-molecular-testing 2026-03-05 monthly 0.7 https://oncdata.com/oncofertility-meaghan-delaney 2026-03-02 monthly 0.7 https://oncdata.com/the-hidden-burden-of-rarity-navigating-the-rare-cancer-journey-with-claire-saxton-mba 2026-02-27 monthly 0.7 https://oncdata.com/acalabrutinib-with-venetoclax-approved-for-previously-untreated-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma 2026-02-24 monthly 0.7 https://oncdata.com/cholangiocarcinoma-awareness-month-2026-kannan-thanikachalam-md 2026-02-23 monthly 0.7 https://oncdata.com/national-caregivers-day-badt-hundal 2026-02-20 monthly 0.7 https://oncdata.com/additional-advances-biliary-tract-cancer 2026-02-19 monthly 0.7 https://oncdata.com/working-with-cancer-employer-support-clark-spitaletta 2026-02-17 monthly 0.7 https://oncdata.com/prevention-in-practice-hadfield-hundal 2026-02-12 monthly 0.7 https://oncdata.com/multicancer-early-detection-understanding-the-science-and-promoting-practical-application 2026-02-11 monthly 0.7 https://oncdata.com/oncology-unfiltered-financial-toxicity 2026-02-05 monthly 0.7 https://oncdata.com/world-cancer-day-hundal-werner 2026-02-04 monthly 0.7 https://oncdata.com/how-ai-can-empower-community-oncologists-oncorx-insights 2026-02-02 monthly 0.7 https://oncdata.com/anitocabtagene-autoleucel-krina-patel-md-msc 2026-01-30 monthly 0.7 https://oncdata.com/daratumumab-and-hyaluronidase-fihj-plus-vrd-approved-for-transplant-ineligible-newly-diagnosed-multiple-myeloma 2026-01-30 monthly 0.7 https://oncdata.com/world-cancer-day-cancer-support-community 2026-01-29 monthly 0.7 https://oncdata.com/additional-advances-in-melanoma-research-and-clinical-trials-with-michael-davies-md-phd 2026-01-28 monthly 0.7 https://oncdata.com/cybersecurity-patient-safety-how-this-plays-out-in-oncology 2026-01-28 monthly 0.7 https://oncdata.com/optimizing-clinical-strategies-for-successful-stem-cell-mobilization-outcomes-in-multiple-myeloma 2026-01-28 monthly 0.7 https://oncdata.com/trastuzumab-deruxtecan-pertuzumab-approved-her2-positive-breast-cancer 2026-01-28 monthly 0.7 https://oncdata.com/nurse-led-telehealth-yolanda-vanriel 2026-01-28 monthly 0.7 https://oncdata.com/systemic-mastocytosis-webinar-preview 2026-01-28 monthly 0.7 https://oncdata.com/breast-cancer-screening-welman-hundal 2026-01-12 monthly 0.7 https://oncdata.com/sabcs-2025-chase-hundal 2026-01-08 monthly 0.7 https://oncdata.com/navigating-mrd-as-an-end-point-banerjee-richardson 2026-01-06 monthly 0.7 https://oncdata.com/rucaparib-approved-for-metastatic-castration-resistant-prostate-cancer 2025-12-30 monthly 0.7 https://oncdata.com/niraparib-aap-approved-brca2-mutated-metastatic-cspc 2025-12-22 monthly 0.7 https://oncdata.com/her2-mutant-nsclc-webinar-preview 2025-12-19 monthly 0.7 https://oncdata.com/lisocabtagene-maraleucel-approved-relapsed-refractory-marginal-zone-lymphoma 2025-12-18 monthly 0.7 https://oncdata.com/durvalumab-approved-gastric-or-gastroesophageal-junction-adenocarcinoma 2025-12-18 monthly 0.7 https://oncdata.com/how-ai-is-redefining-lung-cancer-screening-precision 2025-12-15 monthly 0.7 https://oncdata.com/jasmin-hundal-esmo-breast-cancer 2025-12-11 monthly 0.7 https://oncdata.com/pembrolizumab-enfortumab-vedotin-ejfv-combination-approved-for-muscle-invasive-bladder-cancer 2025-12-09 monthly 0.7 https://oncdata.com/tarlatamab-dlle-approved-for-relapsed-extensive-stage-small-cell-lung-cancer 2025-12-08 monthly 0.7 https://oncdata.com/car-t-in-practice-ehsan-malek 2025-12-08 monthly 0.7 https://oncdata.com/advancing-community-oncology-hadfield-hammonds 2025-12-03 monthly 0.7 https://oncdata.com/manta-cares-samira-daswani 2025-12-01 monthly 0.7 https://oncdata.com/stephen-freedland-murilo-luz-esmo-2025 2025-11-24 monthly 0.7 https://oncdata.com/sevabertinib-granted-accelerated-approval-for-non-squamous-nsclc 2025-11-24 monthly 0.7 https://oncdata.com/epcoritamab-bysp-approved-for-relapsed-refractory-follicular-lymphoma 2025-11-21 monthly 0.7 https://oncdata.com/embark-esmo-stephen-freedland 2025-11-20 monthly 0.7 https://oncdata.com/ziftomenib-approved-for-relapsed-refractory-aml-with-susceptible-npm1-mutation 2025-11-19 monthly 0.7 https://oncdata.com/adaptive-intelligence-prostate-cancer-radiation 2025-11-18 monthly 0.7 https://oncdata.com/oncdata-welcomes-editor-in-chief-matthew-hadfield 2025-11-13 monthly 0.7 https://oncdata.com/navigating-new-frontiers-in-oncology-editor-in-chief 2025-11-13 monthly 0.7 https://oncdata.com/daratumumab-and-hyaluronidase-fihj-approved-for-high-risk-smoldering-multiple-myeloma 2025-11-12 monthly 0.7 https://oncdata.com/mary-pasquinelli-sybil-ai 2025-11-10 monthly 0.7 https://oncdata.com/sean-collins-hydrogel-spacers-prostate-cancer 2025-11-06 monthly 0.7 https://oncdata.com/revumenib-approved-for-relapsed-refractory-aml-with-susceptible-npm1-mutation 2025-10-30 monthly 0.7 https://oncdata.com/mars-2-mesothelioma 2025-10-28 monthly 0.7 https://oncdata.com/improving-oncologic-and-genetic-management-of-von-hippel-lindau-disease 2025-10-27 monthly 0.7 https://oncdata.com/belantamab-mafodotin-blmf-combination-approved-for-relapsed-refractory-multiple-myeloma 2025-10-24 monthly 0.7 https://oncdata.com/breast-cancer-fear-of-recurrence 2025-10-23 monthly 0.7 https://oncdata.com/beyond-the-pink-breast-cancer-awareness-month 2025-10-16 monthly 0.7 https://oncdata.com/ai-co-scientist 2025-10-14 monthly 0.7 https://oncdata.com/cemiplimab-approved-for-adjuvant-treatment-of-high-risk-cscc 2025-10-13 monthly 0.7 https://oncdata.com/breast-cancer-awareness-month-kurian-hundal 2025-10-09 monthly 0.7 https://oncdata.com/travis-osterman-ai-informatics 2025-10-07 monthly 0.7 https://oncdata.com/lurbinectedin-plus-atezolizumab-approved-for-maintenance-treatment-in-es-sclc-after-induction-therapy 2025-10-06 monthly 0.7 https://oncdata.com/imlunestrant-breast-cancer-komal-jhaveri 2025-10-02 monthly 0.7 https://oncdata.com/pembrolizumab-plus-berahyaluronidase-alfa-pmph-approved-for-subcutaneous-administration-across-solid-tumor-indications 2025-09-29 monthly 0.7 https://oncdata.com/world-lung-day-advancing-equity-through-low-dose-lung-cancer-screening 2025-09-25 monthly 0.7 https://oncdata.com/national-womens-health-and-fitness-day-hundal 2025-09-24 monthly 0.7 https://oncdata.com/pain-awareness-month-mccollom-hundal 2025-09-22 monthly 0.7 https://oncdata.com/the-future-of-fda-guidance-trial-design-and-accelerated-approvals 2025-09-18 monthly 0.7 https://oncdata.com/ana-baramidze-cemiplimab 2025-09-16 monthly 0.7 https://oncdata.com/lessons-from-year-one-in-oncology-practice 2025-09-11 monthly 0.7 https://oncdata.com/selumetinibs-pediatric-approval-expanded-for-neurofibromatosis-type-1-with-symptomatic-inoperable-plexiform-neurofibromas 2025-09-11 monthly 0.7 https://oncdata.com/gemcitabine-intravesical-system-approved-for-bcg-unresponsive-non-muscle-invasive-bladder-cancer 2025-09-10 monthly 0.7 https://oncdata.com/from-knowledge-to-practice-ai-in-oncology 2025-09-09 monthly 0.7 https://oncdata.com/ai-ascomind 2025-09-04 monthly 0.7 https://oncdata.com/tailoring-treatment-and-building-confidence-in-management-of-hemophilia 2025-08-29 monthly 0.7 https://oncdata.com/dordaviprone-approval-patrick-wen 2025-08-26 monthly 0.7 https://oncdata.com/summer-sun-safety-month-matthew-hadfield 2025-08-21 monthly 0.7 https://oncdata.com/https-oncdata-com-world-breast-cancer-research-day-connie-visovsky 2025-08-18 monthly 0.7 https://oncdata.com/zongertinib-granted-accelerated-approval-for-her2-tkd-mutated-non-squamous-nsclc 2025-08-15 monthly 0.7 https://oncdata.com/digital-and-social-technology-blog 2025-08-13 monthly 0.7 https://oncdata.com/dordaviprone-granted-accelerated-approval-for-h3-k27m-mutant-diffuse-midline-glioma 2025-08-12 monthly 0.7 https://oncdata.com/rp1-fda-hadfield-moser 2025-08-11 monthly 0.7 https://oncdata.com/genetic-counseling-additional-advances 2025-08-08 monthly 0.7 https://oncdata.com/jasmin-hundal-mascc-highlights 2025-08-04 monthly 0.7 https://oncdata.com/her2-nsclc-additional-advances 2025-08-01 monthly 0.7 https://oncdata.com/jasmin-hundal-asco-breast-cancer 2025-07-31 monthly 0.7 https://oncdata.com/multicancer-early-detection-fellows-perspective 2025-07-29 monthly 0.7 https://oncdata.com/hnscc-outcomes 2025-07-24 monthly 0.7 https://oncdata.com/letter-from-the-editor-challenge-trial 2025-07-23 monthly 0.7 https://oncdata.com/mced-additional-advances 2025-07-21 monthly 0.7 https://oncdata.com/dedifferentiated-liposarcoma-additional-insights 2025-07-17 monthly 0.7 https://oncdata.com/glioblastoma-awareness-day-ajay-abad 2025-07-16 monthly 0.7 https://oncdata.com/ai-at-asco 2025-07-14 monthly 0.7 https://oncdata.com/gayathri-namasivayam-asco 2025-07-11 monthly 0.7 https://oncdata.com/nets-webinar-preview 2025-07-10 monthly 0.7 https://oncdata.com/sunvozertinib-approved-for-egfr-exon-20-insertion-mutation-positive-nsclc 2025-07-08 monthly 0.7 https://oncdata.com/asco-exercise-freedland-gong 2025-07-07 monthly 0.7 https://oncdata.com/linvoseltamab-gcpt-approved-for-relapsed-or-refractory-multiple-myeloma 2025-07-03 monthly 0.7 https://oncdata.com/natural-disaster-asco-manali-patel 2025-06-30 monthly 0.7 https://oncdata.com/datopotamab-deruxtecan-dlnk-granted-accelerated-approval-for-egfr-mutated-nsclc 2025-06-25 monthly 0.7 https://oncdata.com/abigail-zamorano-caregivers 2025-06-24 monthly 0.7 https://oncdata.com/tafasitamab-cxix-approved-for-relapsed-or-refractory-follicular-lymphoma 2025-06-23 monthly 0.7 https://oncdata.com/world-kidney-cancer-day-david-maj 2025-06-19 monthly 0.7 https://oncdata.com/pride-month-lauren-ghazal-jasmin-hundal 2025-06-18 monthly 0.7 https://oncdata.com/pembrolizumab-approved-for-perioperative-treatment-of-resectable-locally-advanced-head-and-neck-squamous-cell-carcinoma 2025-06-18 monthly 0.7 https://oncdata.com/biliary-tract-cancer-position-statement 2025-06-17 monthly 0.7 https://oncdata.com/nursing-assistants-day-2025 2025-06-17 monthly 0.7 https://oncdata.com/national-cancer-survivors-month-darcy-burbage 2025-06-16 monthly 0.7 https://oncdata.com/mitomycin-intravesical-solution-approved-for-low-grade-non-muscle-invasive-bladder-cancer 2025-06-16 monthly 0.7 https://oncdata.com/taletrectinib-approved-for-ros1-positive-non-small-cell-lung-cancer 2025-06-13 monthly 0.7 https://oncdata.com/mens-health-week-stephen-freedland 2025-06-11 monthly 0.7 https://oncdata.com/social-determinants-of-health-amy-osullivan 2025-06-09 monthly 0.7 https://oncdata.com/brain-tumor-awareness-day-ourbrainbank 2025-06-08 monthly 0.7 https://oncdata.com/darolutamide-approved-for-metastatic-castration-sensitive-prostate-cancer 2025-06-05 monthly 0.7 https://oncdata.com/moving-beyond-tradition-roles-with-ai-in-the-era-of-precision-medicine 2025-06-05 monthly 0.7 https://oncdata.com/standard-model-biomedicine 2025-06-04 monthly 0.7 https://oncdata.com/tackling-cancer-stigma-gretchen-mcnally 2025-06-03 monthly 0.7 https://oncdata.com/employee-wellness-month-jeri-lowman 2025-06-02 monthly 0.7 https://oncdata.com/world-no-tobacco-day-maureen-obrien 2025-05-31 monthly 0.7 https://oncdata.com/older-americans-month-carolina-uranga 2025-05-29 monthly 0.7 https://oncdata.com/oncology-nursing-month-pinheiro 2025-05-27 monthly 0.7 https://oncdata.com/bladder-cancer-awareness-lisa-herms 2025-05-23 monthly 0.7 https://oncdata.com/brighter-horizons-in-neuro-oncology 2025-05-21 monthly 0.7 https://oncdata.com/reimagining-oncology-nursing-through-ai 2025-05-21 monthly 0.7 https://oncdata.com/oncology-nursing-month-gilanie-de-castro 2025-05-19 monthly 0.7 https://oncdata.com/retifanlimab-dlwr-approved-for-advanced-squamous-cell-carcinoma-of-the-anal-canal 2025-05-19 monthly 0.7 https://oncdata.com/womens-health-week-chi-chen-hong 2025-05-16 monthly 0.7 https://oncdata.com/telisotuzumab-vedotin-tllv-receives-accelerated-approval-for-high-c-met-non-squamous-nsclc 2025-05-16 monthly 0.7 https://oncdata.com/belzutifan-approved-for-advanced-pheochromocytoma-and-paraganglioma 2025-05-15 monthly 0.7 https://oncdata.com/womens-health-week-valerie-brutus 2025-05-15 monthly 0.7 https://oncdata.com/womens-health-week-connie-visovsky 2025-05-14 monthly 0.7 https://oncdata.com/womens-health-week-gretchen-mcnally 2025-05-13 monthly 0.7 https://oncdata.com/oncology-nursing-month-martin-michalowski 2025-05-12 monthly 0.7 https://oncdata.com/womens-health-week-jasmin-hundal 2025-05-09 monthly 0.7 https://oncdata.com/avutometinib-and-defactinib-granted-accelerated-approval-for-kras-mutated-low-grade-serous-ovarian-cancer 2025-05-08 monthly 0.7 https://oncdata.com/join-vhl-awareness-month 2025-05-08 monthly 0.7 https://oncdata.com/oncology-nursing-month-eileen-hacker 2025-05-06 monthly 0.7 https://oncdata.com/melanoma-monday-matthew-hadfield 2025-05-05 monthly 0.7 https://oncdata.com/what-the-oncology-field-can-learn-from-the-white-lotus 2025-04-30 monthly 0.7 https://oncdata.com/penpulimab-kcqx-approved-for-non-keratinizing-nasopharyngeal-carcinoma 2025-04-30 monthly 0.7 https://oncdata.com/join-world-health-day-2025 2025-04-28 monthly 0.7 https://oncdata.com/harnessing-ai-for-early-lung-cancer-detection-qure-ais-innovations-and-impact 2025-04-24 monthly 0.7 https://oncdata.com/national-minority-health-month-2025 2025-04-23 monthly 0.7 https://oncdata.com/aml-awareness-day-tristan-knight 2025-04-21 monthly 0.7 https://oncdata.com/testicular-cancer-awareness-month-eric-zack 2025-04-17 monthly 0.7 https://oncdata.com/theranostics-in-prostate-cancer 2025-04-16 monthly 0.7 https://oncdata.com/precisca-mohammad-jahanzeb 2025-04-15 monthly 0.7 https://oncdata.com/nivolumab-and-ipilimumab-approved-for-advanced-hepatocellular-carcinoma 2025-04-14 monthly 0.7 https://oncdata.com/head-and-neck-cancer-awareness-month-2025 2025-04-10 monthly 0.7 https://oncdata.com/nivolumab-and-ipilimumab-approved-for-msi-h-dmmr-colorectal-cancer 2025-04-09 monthly 0.7 https://oncdata.com/rrmm-task-force-additional-advances 2025-04-09 monthly 0.7 https://oncdata.com/esophageal-cancer-awareness-month-harry-yoon 2025-04-02 monthly 0.7 https://oncdata.com/durvalumab-approved-for-muscle-invasive-bladder-cancer 2025-04-01 monthly 0.7 https://oncdata.com/fda-expands-indication-for-lutetium-lu-177-vipivotide-tetraxetan-in-psma-positive-mcrpc 2025-03-31 monthly 0.7 https://oncdata.com/megan-herr-car-t-cell-scoring 2025-03-31 monthly 0.7 https://oncdata.com/fda-approves-cabozantinib-for-pancreatic-and-extra-pancreatic-neuroendocrine-tumors 2025-03-28 monthly 0.7 https://oncdata.com/national-doctors-day-2025 2025-03-26 monthly 0.7 https://oncdata.com/car-t-second-primary-malignancies-clinic-conversation 2025-03-25 monthly 0.7 https://oncdata.com/cultivating-proficiency-in-mrd-testing-for-the-management-of-hematologic-malignancies 2025-03-21 monthly 0.7 https://oncdata.com/pembrolizumab-approved-for-her2-positive-gastric-or-gastroesophageal-junction-adenocarcinoma 2025-03-20 monthly 0.7 https://oncdata.com/transforming-clinical-trial-matching-with-ai 2025-03-19 monthly 0.7 https://oncdata.com/neoantigen-vaccines-rcc-clinic-conversation-of-the-week 2025-03-18 monthly 0.7 https://oncdata.com/rare-disease-day-2025 2025-03-17 monthly 0.7 https://oncdata.com/fellow-of-the-month-mehndi-dandwani 2025-03-17 monthly 0.7 https://oncdata.com/asct-mm-additional-advances 2025-03-12 monthly 0.7 https://oncdata.com/checkmate-8hw-clinic-converation-of-the-week 2025-03-11 monthly 0.7 https://oncdata.com/international-womens-day-2025 2025-03-07 monthly 0.7 https://oncdata.com/tumor-infiltrating-lymphocytes-technology-melanoma 2025-03-06 monthly 0.7 https://oncdata.com/datopotamab-clinic-conversation-of-the-week 2025-03-04 monthly 0.7 https://oncdata.com/rcc-additional-advances 2025-03-03 monthly 0.7 https://oncdata.com/fda-new-approval-guidance-harpreet-singh 2025-02-27 monthly 0.7 https://oncdata.com/talquetamab-teclistimab-clinic-conversation-of-the-week 2025-02-25 monthly 0.7 https://oncdata.com/vimseltinib-approved-for-symptomatic-tenosynovial-giant-cell-tumor 2025-02-19 monthly 0.7 https://oncdata.com/national-cancer-prevention-month-sally-werner 2025-02-19 monthly 0.7 https://oncdata.com/brentuximab-vedotin-in-combination-with-lenalidomide-and-rituximab-approved-for-relapsed-or-refractory-large-b-cell-lymphoma 2025-02-18 monthly 0.7 https://oncdata.com/roswell-park-gmp-engineering-and-cell-manufacturing-facility 2025-02-14 monthly 0.7 https://oncdata.com/treosulfan-plus-fludarabine-approved-as-allohsct-preparative-regimen-for-aml-and-mds 2025-02-12 monthly 0.7 https://oncdata.com/digital-pathology-osama-khan 2025-02-10 monthly 0.7 https://oncdata.com/fellow-of-the-month-wint-yan-arthur-aung 2025-02-07 monthly 0.7 https://oncdata.com/new-frontiers-in-2025-with-ai 2025-02-03 monthly 0.7 https://oncdata.com/additional-advances-in-hemophilia-treatment 2025-01-31 monthly 0.7 https://oncdata.com/amplifying-nursing-proficiency-for-the-management-of-immune-related-adverse-events 2025-01-23 monthly 0.7 https://oncdata.com/how-ai-is-revolutionizing-precision-oncology 2025-01-23 monthly 0.7 https://oncdata.com/ash-trainee-council-kaitlyn-dykes-maya-abdallah-2 2025-01-22 monthly 0.7 https://oncdata.com/acalabrutinib-plus-bendamustine-and-rituximab-approved-for-previously-untreated-mantle-cell-lymphoma 2025-01-20 monthly 0.7 https://oncdata.com/mendel-ai-with-kristin-maloney 2025-01-16 monthly 0.7 https://oncdata.com/imlunestrant-clinic-conversation-of-the-week 2025-01-14 monthly 0.7 https://oncdata.com/cancer-support-community-breast-cancer-tolerability-sabcs 2025-01-10 monthly 0.7 https://oncdata.com/understanding-the-role-of-social-determinants-in-multiple-myeloma-care 2025-01-09 monthly 0.7 https://oncdata.com/what-oncologists-and-mathletes-have-in-common-during-2025 2025-01-07 monthly 0.7 https://oncdata.com/ponsegromab-clinic-conversation-of-the-week 2025-01-07 monthly 0.7 https://oncdata.com/venetoclax-immune-function-chronic-lymphocytic-leukemia 2025-01-06 monthly 0.7 https://oncdata.com/cosibelimab-new-option-for-cutaneous-squamous-cell-carcinoma 2025-01-03 monthly 0.7 https://oncdata.com/nivolumab-and-hyaluronidase-nvhy-approved-for-subcutaneous-injection 2024-12-31 monthly 0.7 https://oncdata.com/ai-applications-in-thymoma-diagnosis-and-management 2024-12-30 monthly 0.7 https://oncdata.com/encorafenib-cetuximab-mfolfox6-approved-for-braf-v600e-crc 2024-12-27 monthly 0.7 https://oncdata.com/remestemcel-l-approved-for-pediatric-acute-gvhd 2024-12-26 monthly 0.7 https://oncdata.com/ensartinib-approved-for-alk-positive-nsclc 2024-12-26 monthly 0.7 https://oncdata.com/systems-based-hematology-richard-godby 2024-12-23 monthly 0.7 https://oncdata.com/cancer-support-community-treatment-tolerability-ash 2024-12-20 monthly 0.7 https://oncdata.com/ctdna-in-breast-cancer-sabcs 2024-12-19 monthly 0.7 https://oncdata.com/epcore-cll-1-an-advance-in-treating-relapsed-refractory-chronic-lymphocytic-leukemia 2024-12-19 monthly 0.7 https://oncdata.com/zenocutuzumab-clinic-conversation-of-the-week 2024-12-17 monthly 0.7 https://oncdata.com/cosibelimab-ipdl-approved-for-metastatic-or-locally-advanced-cutaneous-squamous-cell-carcinoma 2024-12-16 monthly 0.7 https://oncdata.com/strength-in-motion-resistance-training-in-multiple-myeloma-janine-joseph 2024-12-16 monthly 0.7 https://oncdata.com/ontada-microsoft-azure-ai-real-world-data-processing-in-oncology 2024-12-12 monthly 0.7 https://oncdata.com/zanidatamab-biliary-tract-cancer-james-harding 2024-12-11 monthly 0.7 https://oncdata.com/aall1731-trial-clinic-conversation-of-the-week 2024-12-10 monthly 0.7 https://oncdata.com/durvalumab-approved-for-limited-stage-small-cell-lung-cancer 2024-12-05 monthly 0.7 https://oncdata.com/dedifferentiated-liposarcoma-position-statement-and-podcast 2024-12-04 monthly 0.7 https://oncdata.com/indigo-trial-clinic-conversation-of-the-week 2024-12-03 monthly 0.7 https://oncdata.com/american-diabetes-month-2024 2024-11-27 monthly 0.7 https://oncdata.com/lung-cancer-awareness-month-2024 2024-11-26 monthly 0.7 https://oncdata.com/fellow-of-the-month-nida-khan 2024-11-25 monthly 0.7 https://oncdata.com/national-family-caregivers-month-2024 2024-11-22 monthly 0.7 https://oncdata.com/ai-advances-in-cancer-research 2024-11-21 monthly 0.7 https://oncdata.com/advancing-clinical-expertise-in-the-oncologic-and-pathologic-management-of-triple-negative-breast-cancer 2024-11-20 monthly 0.7 https://oncdata.com/revumenib-approved-for-relapsed-or-refractory-acute-leukemia-with-a-kmt2a-translocation 2024-11-18 monthly 0.7 https://oncdata.com/carcinoid-cancer-awareness-month-2024 2024-11-15 monthly 0.7 https://oncdata.com/transgender-awareness-week-prostate-cancer 2024-11-14 monthly 0.7 https://oncdata.com/optimizing-clinical-strategies-for-effective-management-of-soft-tissue-sarcomas 2024-11-13 monthly 0.7 https://oncdata.com/benefit-trial-clinic-conversation-of-the-week 2024-11-12 monthly 0.7 https://oncdata.com/obecabtagene-autoleucel-approved-for-relapsed-or-refractory-b-cell-precursor-acute-lymphoblastic-leukemia 2024-11-12 monthly 0.7 https://oncdata.com/elevating-clinician-competence-in-the-management-of-early-stage-non-small-cell-lung-cancer 2024-11-08 monthly 0.7 https://oncdata.com/artera-personalizing-treatment-decisions-in-prostate-cancer 2024-11-08 monthly 0.7 https://oncdata.com/inspirogene-revolutionizing-the-cell-and-gene-therapy-landscape 2024-11-04 monthly 0.7 https://oncdata.com/jimmy-carter-editors-column-october-2024 2024-10-31 monthly 0.7 https://oncdata.com/asciminib-accelerated-approval-newly-diagnosed-chronic-myeloid-leukemia 2024-10-31 monthly 0.7 https://oncdata.com/kras-story-in-lung-cancer-dosing-lessons-to-learn-from-sotorasib 2024-10-30 monthly 0.7 https://oncdata.com/opportunities-for-ai-in-health-equity-medical-education-and-beyond 2024-10-25 monthly 0.7 https://oncdata.com/nbcf-helping-women-now-douglas-feil-megan-claire-chase 2024-10-24 monthly 0.7 https://oncdata.com/national-healthcare-quality-week-matthew-hadfield-lauren-ghazal 2024-10-22 monthly 0.7 https://oncdata.com/zolbetuximab-clzb-approved-for-gastroesophageal-junction-adenocarcinoma-2 2024-10-22 monthly 0.7 https://oncdata.com/fellow-of-the-month-jasmin-hundal 2024-10-18 monthly 0.7 https://oncdata.com/revolutionizing-cancer-diagnostics-through-ai-powered-analysis 2024-10-17 monthly 0.7 https://oncdata.com/advancing-clinician-expertise-in-recurrent-and-metastatic-head-and-neck-cancer 2024-10-16 monthly 0.7 https://oncdata.com/lobular-breast-cancer-awareness-day-making-strides-in-research-with-jason-mouabbi 2024-10-15 monthly 0.7 https://oncdata.com/approval-of-inavolisib-a-leap-forward-in-precision-breast-cancer-therapy-jason-mouabbi 2024-10-14 monthly 0.7 https://oncdata.com/world-hospice-and-palliative-care-day-richa-thakur-nida-khan 2024-10-11 monthly 0.7 https://oncdata.com/inavolisib-plus-palbociclib-and-fulvestrant-approved-for-endocrine-resistant-pik3ca-mutated-hr-positive-her2-negative-advanced-breast-cancer 2024-10-11 monthly 0.7 https://oncdata.com/world-mental-health-day-perspectives-from-both-patient-and-provider 2024-10-10 monthly 0.7 https://oncdata.com/improving-confidence-with-bcma-directed-therapies-in-relapsed-refractory-multiple-myeloma 2024-10-09 monthly 0.7 https://oncdata.com/additional-advances-in-head-and-neck-squamous-cell-carcinoma 2024-10-04 monthly 0.7 https://oncdata.com/nivolumab-approved-for-neoadjuvant-adjuvant-treatment-of-resectable-non-small-cell-lung-cancer 2024-10-03 monthly 0.7 https://oncdata.com/studying-rare-cancers-current-methodologies-and-future-opportunities 2024-10-02 monthly 0.7 https://oncdata.com/selpercatinib-approved-for-ret-fusion-positive-medullary-thyroid-cancer 2024-09-30 monthly 0.7 https://oncdata.com/osimertinib-approved-for-locally-advanced-unresectable-stage-iii-non-small-cell-lung-cancer-following-chemoradiation-therapy 2024-09-26 monthly 0.7 https://oncdata.com/childhood-cancer-awareness-month-a-primer-on-pediatric-cancers 2024-09-26 monthly 0.7 https://oncdata.com/isatuximab-irfc-plus-bortezomib-lenalidomide-and-dexamethasone-approved-for-newly-diagnosed-multiple-myeloma 2024-09-25 monthly 0.7 https://oncdata.com/world-cancer-research-day-trends-for-the-future 2024-09-24 monthly 0.7 https://oncdata.com/pain-awareness-month-a-dual-perspective-on-navigating-cancer-pain 2024-09-23 monthly 0.7 https://oncdata.com/prostate-cancer-awareness-month-overcoming-disparities 2024-09-23 monthly 0.7 https://oncdata.com/impacts-of-ai-in-the-evolving-oncology-landscape 2024-09-23 monthly 0.7 https://oncdata.com/amivantamab-vmjw-plus-chemotherapy-approved-for-non-small-cell-lung-cancer-with-egfr-exon-19-deletions-or-l858r-mutations 2024-09-20 monthly 0.7 https://oncdata.com/blood-cancer-awareness-month-navigating-hereditary-hematologic-malignancy-genetics 2024-09-20 monthly 0.7 https://oncdata.com/lymphoma-awareness-month-nursing-and-patient-advocacy-perspectives 2024-09-19 monthly 0.7 https://oncdata.com/pembrolizumab-plus-chemotherapy-approved-for-unresectable-advanced-or-metastatic-malignant-pleural-mesothelioma 2024-09-19 monthly 0.7 https://oncdata.com/ribociclib-plus-aromatase-inhibitor-and-ribociclib-letrozole-co-pack-approved-for-early-high-risk-breast-cancer 2024-09-18 monthly 0.7 https://oncdata.com/take-a-loved-one-to-the-doctor-day 2024-09-17 monthly 0.7 https://oncdata.com/prostate-cancer-awareness-month 2024-09-12 monthly 0.7 https://oncdata.com/enhancing-knowledge-of-emerging-treatment-strategies-and-latest-advances-in-follicular-lymphoma-therapy 2024-09-11 monthly 0.7 https://oncdata.com/investigating-the-impact-of-multiple-pharmacy-use-and-medication-adherence-in-colorectal-cancer 2024-09-09 monthly 0.7 https://oncdata.com/additional-advances-in-immune-related-adverse-events-research-and-clinical-trials-beth-sandy 2024-09-06 monthly 0.7 https://oncdata.com/icad-creating-a-world-where-cancer-cant-hide 2024-09-05 monthly 0.7 https://oncdata.com/i3-health-and-oncology-data-advisor-publish-multiple-myeloma-task-force-position-statement-in-blood-cancer-journal-2 2024-09-05 monthly 0.7 https://oncdata.com/i3-health-and-oncology-data-advisor-publish-multiple-myeloma-task-force-position-statement-in-blood-cancer-journal 2024-09-05 monthly 0.7 https://oncdata.com/national-grief-awareness-day 2024-08-30 monthly 0.7 https://oncdata.com/international-overdose-awareness-day-erasing-the-stigma 2024-08-29 monthly 0.7 https://oncdata.com/ai-in-pathology-transforming-oncology-diagnosis-and-treatment 2024-08-28 monthly 0.7 https://oncdata.com/improving-understanding-of-evolved-treatment-concepts-and-new-data-in-advanced-prostate-cancer 2024-08-26 monthly 0.7 https://oncdata.com/palliative-care-and-oncology-partners-in-patient-care 2024-08-23 monthly 0.7 https://oncdata.com/lazertinib-plus-amivantamab-vmjw-approved-for-non-small-cell-lung-cancer 2024-08-22 monthly 0.7 https://oncdata.com/neoadjuvant-adjuvant-durvalumab-approved-for-resectable-non-small-cell-lung-cancer 2024-08-20 monthly 0.7 https://oncdata.com/navigating-the-fellowship-application-experience-with-jorge-avila-md 2024-08-20 monthly 0.7 https://oncdata.com/axatilimab-csfr-approved-for-chronic-graft-versus-host-disease 2024-08-19 monthly 0.7 https://oncdata.com/act-for-humanity-advocating-for-aid-workers-on-world-humanitarian-day 2024-08-19 monthly 0.7 https://oncdata.com/world-breast-cancer-research-day-making-strides-in-neuropathy-research 2024-08-16 monthly 0.7 https://oncdata.com/summer-sun-safety-month-tristan-knight-matthew-hadfield 2024-08-15 monthly 0.7 https://oncdata.com/enhancing-value-based-care-and-treatment-of-newly-diagnosed-multiple-myeloma 2024-08-14 monthly 0.7 https://oncdata.com/vorasidenib-approved-for-astrocytoma-or-oligodendroglioma 2024-08-09 monthly 0.7 https://oncdata.com/statistically-significant-knowledge-gains-for-esophagogastric-cancer-care 2024-08-09 monthly 0.7 https://oncdata.com/the-digital-fingerprint-accelerating-personalized-drug-discovery-and-development 2024-08-08 monthly 0.7 https://oncdata.com/optimizing-sacituzumab-govitecan-tolerability-in-early-tnbc-antonio-llombart-cussac 2024-08-05 monthly 0.7 https://oncdata.com/afamitresgene-autoleucel-granted-accelerated-approval-as-first-gene-therapy-for-synovial-sarcoma 2024-08-05 monthly 0.7 https://oncdata.com/dostarlimab-gxly-plus-chemotherapy-receives-expanded-approval-for-endometrial-cancer 2024-08-02 monthly 0.7 https://oncdata.com/interpreting-psa-values-in-transgender-women-for-optimal-prostate-cancer-screening 2024-08-02 monthly 0.7 https://oncdata.com/world-lung-cancer-day-2024 2024-08-01 monthly 0.7 https://oncdata.com/new-updates-on-the-evolving-landscape-of-ai-in-oncology 2024-07-31 monthly 0.7 https://oncdata.com/leading-transplantation-support-and-research-at-nmdp-and-cibmtr 2024-07-31 monthly 0.7 https://oncdata.com/daratumumab-and-hyaluronidase-fihj-approved-for-newly-diagnosed-multiple-myeloma 2024-07-31 monthly 0.7 https://oncdata.com/national-minority-mental-health-awareness-month 2024-07-30 monthly 0.7 https://oncdata.com/sarcoma-awareness-month-partnering-to-provide-optimal-outcomes 2024-07-29 monthly 0.7 https://oncdata.com/enhancing-knowledge-of-advanced-renal-cell-carcinoma-treatment-and-patient-care 2024-07-26 monthly 0.7 https://oncdata.com/caringbridge-ensuring-no-one-goes-through-a-health-journey-alone-tia-newcomer 2024-07-26 monthly 0.7 https://oncdata.com/reimagining-surgery-through-ai-and-computer-vision-technology-tamir-wolf 2024-07-25 monthly 0.7 https://oncdata.com/rahul-banerjee-editors-column-july-2024-2 2024-07-24 monthly 0.7 https://oncdata.com/rahul-banerjee-editors-column-july-2024 2024-07-24 monthly 0.7 https://oncdata.com/oncology-data-advisor-receives-apex-award-of-excellence-2024-2 2024-07-24 monthly 0.7 https://oncdata.com/oncology-data-advisor-receives-apex-award-of-excellence-2024 2024-07-24 monthly 0.7 https://oncdata.com/exploring-association-of-fgfr3-alterations-in-urothelial-cancer-arlene-siefker-radtke 2024-07-22 monthly 0.7 https://oncdata.com/biomarker-documentation-in-the-community-setting-improving-clinical-decision-support 2024-07-19 monthly 0.7 https://oncdata.com/community-oncology-pharmacists-their-crucial-role-and-clinical-impact-andrea-roman 2024-07-18 monthly 0.7 https://oncdata.com/investigating-axicabtagene-ciloleucel-for-relapsed-refractory-central-nervous-system-lymphoma 2024-07-17 monthly 0.7 https://oncdata.com/updated-results-from-spotlight-and-ev-302-with-ahsan-arozullah 2024-07-16 monthly 0.7 https://oncdata.com/wommen-trekking-peru-with-gurbakhash-kaur 2024-07-15 monthly 0.7 https://oncdata.com/cancer-and-careers-with-rebecca-nellis 2024-07-15 monthly 0.7 https://oncdata.com/worth-the-wait-supporting-young-adult-cancer-survivors-on-the-path-to-parenthood 2024-07-12 monthly 0.7 https://oncdata.com/the-latest-data-on-zanidatamab-for-her2-positive-biliary-tract-cancer 2024-07-11 monthly 0.7 https://oncdata.com/intuitively-designing-clinical-trials-to-empower-patients-with-ishwaria-subbiah 2024-07-10 monthly 0.7 https://oncdata.com/combating-health-disparities-through-more-equitable-screening 2024-07-09 monthly 0.7 https://oncdata.com/the-nadina-trial-with-matthew-hadfield 2024-07-08 monthly 0.7 https://oncdata.com/multicancer-early-detection-whats-your-opinion 2024-07-08 monthly 0.7 https://oncdata.com/an-innovative-wellness-and-professional-development-curriculum-for-fellows 2024-07-05 monthly 0.7 https://oncdata.com/best-of-asco-2024-what-patients-need-to-know-2 2024-07-05 monthly 0.7 https://oncdata.com/best-of-asco-2024-what-patients-need-to-know 2024-07-05 monthly 0.7 https://oncdata.com/highlights-of-multiple-myeloma-at-ash-urvi-shah 2024-07-05 monthly 0.7 https://oncdata.com/implementing-a-novel-research-methods-training-curriculum-for-fellows 2024-07-03 monthly 0.7 https://oncdata.com/thinking-globally-broadening-cancer-treatment-equity-around-the-world 2024-07-03 monthly 0.7 https://oncdata.com/the-fellow-on-call-and-fellowship-research-at-asco 2024-07-02 monthly 0.7 https://oncdata.com/representing-symptom-research-and-nursing-at-asco-with-natalie-jackson-carroll 2024-07-02 monthly 0.7 https://oncdata.com/piloting-palliative-care-education-for-fellows-2 2024-07-01 monthly 0.7 https://oncdata.com/piloting-palliative-care-education-for-fellows 2024-07-01 monthly 0.7 https://oncdata.com/sarcoma-foundation-of-american-with-brandi-felser-and-waqas-haque 2024-07-01 monthly 0.7 https://oncdata.com/epcoritamab-granted-accelerated-approval-for-relapsed-refractory-follicular-lymphoma 2024-06-28 monthly 0.7 https://oncdata.com/advocates-for-universal-dpd-dpyd-testing 2024-06-28 monthly 0.7 https://oncdata.com/enzalutamide-patient-reported-outcomes-embark-trial-stephen-freedland 2024-06-28 monthly 0.7 https://oncdata.com/effective-care-for-substance-use-disorders-in-cancer-the-advanced-practice-nurse-perspective 2024-06-27 monthly 0.7 https://oncdata.com/addressing-barriers-to-transplantation-accessibility 2024-06-26 monthly 0.7 https://oncdata.com/improving-long-term-survivorship-care-in-head-and-neck-cancer 2024-06-26 monthly 0.7 https://oncdata.com/oncology-data-advisor-at-asco-2024 2024-06-26 monthly 0.7 https://oncdata.com/adagrasib-plus-cetuximab-granted-accelerated-approval-for-kras-g12cl-mutated-colorectal-cancer 2024-06-25 monthly 0.7 https://oncdata.com/count-me-in-partnering-with-patients-to-accelerate-the-pace-of-cancer-research 2024-06-24 monthly 0.7 https://oncdata.com/qure-ai-with-ranjana-devi-and-waqas-haque 2024-06-24 monthly 0.7 https://oncdata.com/qure-ai-with-ranjana-devi-and-waqas-haque-2 2024-06-24 monthly 0.7 https://oncdata.com/developing-a-polygenic-risk-score-for-tnbc-risk-assessment-in-black-women 2024-06-21 monthly 0.7 https://oncdata.com/harnessing-the-power-of-ai-for-cancer-detection 2024-06-21 monthly 0.7 https://oncdata.com/blue-faery-improving-liver-cancer-care-through-education-and-research 2024-06-20 monthly 0.7 https://oncdata.com/pembrolizumab-with-chemotherapy-approved-for-primary-advanced-or-recurrent-endometrial-carcinoma 2024-06-19 monthly 0.7 https://oncdata.com/highlights-of-brain-tumor-and-cns-research-at-asco-morana-vojnic 2024-06-19 monthly 0.7 https://oncdata.com/blinatumomab-approved-as-consolidation-for-cd19-positive-philadelphia-chromosome-negative-b-cell-precursor-acute-lymphoblastic-leukemia 2024-06-18 monthly 0.7 https://oncdata.com/artful-oncology-psychosocial-oncology-curriculum-for-heme-onc-fellows-jafar-al-mondhiry 2024-06-18 monthly 0.7 https://oncdata.com/representing-fellows-in-evidence-based-wellness-interventions-andrew-hearn 2024-06-17 monthly 0.7 https://oncdata.com/durvalumab-with-chemotherapy-approved-for-mismatch-repair-deficient-primary-advanced-or-recurrent-endometrial-cancer 2024-06-17 monthly 0.7 https://oncdata.com/fellows-forum-live-from-asco-2024-2 2024-06-14 monthly 0.7 https://oncdata.com/join-the-fellows-forum 2024-06-14 monthly 0.7 https://oncdata.com/repotrectinib-granted-accelerated-approval-for-ntrk-gene-fusion-positive-solid-tumors-2 2024-06-14 monthly 0.7 https://oncdata.com/repotrectinib-granted-accelerated-approval-for-ntrk-gene-fusion-positive-solid-tumors 2024-06-14 monthly 0.7 https://oncdata.com/assessing-risk-of-myelosuppression-parp-inhibitors-karan-jatwani 2024-06-14 monthly 0.7 https://oncdata.com/selpercatinib-granted-traditional-approval-for-ret-fusion-positive-thyroid-cancer 2024-06-13 monthly 0.7 https://oncdata.com/understanding-cardiotoxicity-risk-btk-inhibitors-muhammad-salman-faisal 2024-06-13 monthly 0.7 https://oncdata.com/fellows-forum-at-asco-2024 2024-06-13 monthly 0.7 https://oncdata.com/predicting-immunotherapy-benefit-ofer-sharon 2024-06-12 monthly 0.7 https://oncdata.com/fellows-forum-at-asco-2024-2 2024-06-12 monthly 0.7 https://oncdata.com/highlights-of-sarcoma-research-at-asco-2024 2024-06-11 monthly 0.7 https://oncdata.com/exploring-tumor-microenvironment-invasive-lobular-carcinoma 2024-06-10 monthly 0.7 https://oncdata.com/imetelstat-approved-for-low-to-intermediate-1-risk-myelodysplastic-syndromes 2024-06-07 monthly 0.7 https://oncdata.com/precision-health-approach-to-post-treatment-comorbid-diabetes-in-cancer 2024-06-06 monthly 0.7 https://oncdata.com/supporting-nurses-returning-to-work-after-cancer-diagnosis 2024-06-05 monthly 0.7 https://oncdata.com/live-webinar-vhl-2 2024-06-05 monthly 0.7 https://oncdata.com/food-for-thought-nutrition-in-vulnerable-cancer-populations 2024-06-04 monthly 0.7 https://oncdata.com/starting-the-conversation-end-of-life-communication-in-oncology-nursing 2024-06-03 monthly 0.7 https://oncdata.com/lisocabtagene-maraleucel-approved-relapsed-refractory-mantel-cell-lymphoma 2024-05-31 monthly 0.7 https://oncdata.com/mitigating-financial-toxicity-experienced-by-cancer-survivors 2024-05-31 monthly 0.7 https://oncdata.com/selpercatinib-granted-accelerated-approval-for-pediatric-patients-ret-mutations 2024-05-30 monthly 0.7 https://oncdata.com/our-brain-bank-creating-change-in-glioblastoma-treatment 2024-05-30 monthly 0.7 https://oncdata.com/championing-policy-advocacy-in-cancer 2024-05-29 monthly 0.7 https://oncdata.com/speed-dating-bridging-gap-between-dnp-phd-nurses 2024-05-28 monthly 0.7 https://oncdata.com/climate-change-and-healthcare-what-we-can-do-to-help 2024-05-28 monthly 0.7 https://oncdata.com/lisocabtagene-maraleucel-granted-accelerated-approval-follicular-lymphoma-2 2024-05-28 monthly 0.7 https://oncdata.com/lisocabtagene-maraleucel-granted-accelerated-approval-follicular-lymphoma 2024-05-24 monthly 0.7 https://oncdata.com/the-way-ahead-may-2024-2 2024-05-24 monthly 0.7 https://oncdata.com/the-way-ahead-may-2024 2024-05-24 monthly 0.7 https://oncdata.com/ons-lifetime-achievement-award-margaret-barton-burke 2024-05-24 monthly 0.7 https://oncdata.com/incorporating-patient-reported-outcomes-in-oncology-research 2024-05-24 monthly 0.7 https://oncdata.com/brain-tumor-awareness-month-2024-2 2024-05-23 monthly 0.7 https://oncdata.com/brain-tumor-awareness-month-2024 2024-05-23 monthly 0.7 https://oncdata.com/igniting-the-extraordinary-ons-congres-lauren-ghazal 2024-05-22 monthly 0.7 https://oncdata.com/approval-tarlatamab-subsequent-line-treatment-extensive-stage-small-cell-lung-cancer 2024-05-22 monthly 0.7 https://oncdata.com/power-of-persistence-and-perspective-kelsey-tainsh 2024-05-21 monthly 0.7 https://oncdata.com/tackling-disparities-experienced-lgbtq-cancer-survivors 2024-05-20 monthly 0.7 https://oncdata.com/highlights-of-ons-congress-2024-maria-badillo 2024-05-20 monthly 0.7 https://oncdata.com/future-oncology-research-cutting-edge-approaches-using-ai 2024-05-17 monthly 0.7 https://oncdata.com/discussing-cancer-fatalism-risky-healthy-behaviors 2024-05-16 monthly 0.7 https://oncdata.com/smith-center-for-healing-and-the-arts-erin-price-and-laura-pole 2024-05-15 monthly 0.7 https://oncdata.com/launching-genetic-cancer-prevention-clinic 2024-05-14 monthly 0.7 https://oncdata.com/cancer-support-community-editorial-board 2024-05-14 monthly 0.7 https://oncdata.com/providing-evidence-new-product-introductions-nursing 2024-05-13 monthly 0.7 https://oncdata.com/bridging-oncology-nursing-learning-gaps-through-advanced-practice-provider-fellowship 2024-05-10 monthly 0.7 https://oncdata.com/welcome-ons-new-president-jessica-macintyre 2024-05-09 monthly 0.7 https://oncdata.com/ons-2024-playlist 2024-05-08 monthly 0.7 https://oncdata.com/additiona-advances-in-multiple-myeloma-research-and-clinical-trials-rahul-banerjee 2024-05-06 monthly 0.7 https://oncdata.com/recurrent-metastatic-hnscc-answers-to-frequently-asked-questions-with-assuntina-g-sacco-md 2024-05-03 monthly 0.7 https://oncdata.com/every-cure-unlocking-drug-potential-through-artificial-intelligence-with-waqas-haque-md-mph-and-tracey-sikora-co-founder 2024-05-02 monthly 0.7 https://oncdata.com/acute-myeloid-leukemia-aml-awareness-day-evolving-treatment-directions-with-dr-tristan-knight-dr-richa-thakur-and-dr-joseph-kalis 2024-05-01 monthly 0.7 https://oncdata.com/testicular-cancer-awareness-month-improving-detection-management-and-survivorship-with-samuel-kareff-md-mph-waqas-haque-md-mph-and-matthew-hadfield-do 2024-04-30 monthly 0.7 https://oncdata.com/tisotumab-vedotin-tftv-approved-for-metastatic-cervical-cancer 2024-04-30 monthly 0.7 https://oncdata.com/tovorafenib-apporved-for-braf-altered-pediatric-low-grade-glioma 2024-04-30 monthly 0.7 https://oncdata.com/lutetium-lu-177-dotatate-approved-for-pediatric-patients-with-gep-nets 2024-04-29 monthly 0.7 https://oncdata.com/celebrating-head-and-neck-cancer-awareness-month-with-samuel-kareff-md-mph-matthew-hadfield-do-and-nagashree-seetharamu-md 2024-04-24 monthly 0.7 https://oncdata.com/nogapendekin-alfa-inbakicept-pmln-approved-for-bcg-unresponsive-non-muscle-invasive-bladder-cancer 2024-04-23 monthly 0.7 https://oncdata.com/advancing-precision-oncology-through-artificial-intelligence 2024-04-22 monthly 0.7 https://oncdata.com/advancing-precision-oncology-through-artificial-intelligence-2 2024-04-22 monthly 0.7 https://oncdata.com/alectinib-approved-for-adjuvant-treatment-for-alk-positive-non-small-cell-lung-cancer 2024-04-22 monthly 0.7 https://oncdata.com/esophageal-cancer-awareness-month-treatment-advances-and-tools-for-maximizing-tolerability-with-joseph-kalis-pharmd-bcop-matthew-hadfield-do-samuel-kareff-md-mph 2024-04-19 monthly 0.7 https://oncdata.com/linvoseltamab-for-relapsed-refractory-multiple-myeloma-updates-on-the-linker-mm1-trial-from-aacr-2024-with-alankrita-taneja-md-and-sundar-jagannath-md 2024-04-17 monthly 0.7 https://oncdata.com/linvoseltamab-for-relapsed-refractory-multiple-myeloma-aacr 2024-04-17 monthly 0.7 https://oncdata.com/improving-breast-cancer-surgical-outcomes-with-lymphovenous-bypass-with-jason-mouabbi-md-valerie-brutus-md-facs-and-elizabeth-stirling-craig-md 2024-04-15 monthly 0.7 https://oncdata.com/additional-advances-in-her2-positive-metastatic-colorectal-cancer-research-and-clinical-trials-with-christopher-lieu-md 2024-04-12 monthly 0.7 https://oncdata.com/fighting-hereditary-colorectal-cancer-through-genetic-counseling-with-catherine-skefos-ma-ms-cgc-and-julie-moskowitz-ms 2024-04-10 monthly 0.7 https://oncdata.com/fam-trastuzumab-deruxtecan-nxki-receives-accelerated-approval-for-her2-positive-solid-tumors 2024-04-09 monthly 0.7 https://oncdata.com/international-womens-day-perspectives-in-medicine-nursing-and-fellowship 2024-04-09 monthly 0.7 https://oncdata.com/aya-cancer-awareness-week-creating-welcoming-spaces-for-support-and-advocacy-with-dr-lauren-ghazal-megan-claire-chase-and-allison-rosen 2024-04-05 monthly 0.7 https://oncdata.com/additional-advances-in-soft-tissue-sarcoma-with-brian-rubin-md-phd 2024-04-02 monthly 0.7 https://oncdata.com/additional-advances-in-attp-research-and-clinical-trials-with-spero-cataland-md 2024-04-01 monthly 0.7 https://oncdata.com/predicting-immune-related-adverse-events-through-machine-learning-with-oncohost-dr-waqas-haque-dr-matthew-hadfield-and-dr-ofer-sharon 2024-03-31 monthly 0.7 https://oncdata.com/creating-educational-opportunities-during-fellowship-board-exam-prep-live-meetings-and-beyond-with-samuel-kareff-md-mph-and-matthew-hadfield-do 2024-03-31 monthly 0.7 https://oncdata.com/thirty-years-in-the-making-the-groundbreaking-approval-of-lifileucel-for-metastatic-melanoma-with-matthew-hadfield-do-and-richard-carvajal-md 2024-03-31 monthly 0.7 https://oncdata.com/celebrating-national-doctors-day-with-samuel-kareff-md-mph-and-matthew-hadfield-do 2024-03-29 monthly 0.7 https://oncdata.com/kidney-cancer-awareness-month-spotlight-on-genetic-counseling-with-hiam-abdel-salam-ms-cgc-and-donika-saporito-ms 2024-03-29 monthly 0.7 https://oncdata.com/a-case-in-contrasts-how-should-the-media-talk-about-cancer-diagnoses 2024-03-28 monthly 0.7 https://oncdata.com/additional-advances-in-esophagogastric-cancer-research-and-clinical-trials-with-jaffer-ajani-md 2024-03-28 monthly 0.7 https://oncdata.com/an-introduction-to-genetic-counseling-with-hiam-abdel-salam-ms-cgc-and-catherine-skefos-ma-ms-cgc 2024-03-27 monthly 0.7 https://oncdata.com/discovering-research-advances-in-mesothelioma-with-samuel-kareff-md-mph-and-estela-rodriguez-md-mph-2-2 2024-03-26 monthly 0.7 https://oncdata.com/kidney-cancer-awareness-month-discovering-clinical-strategies-to-improve-outcomes-with-dr-samuel-kareff-dr-waqas-haque-and-dr-ulka-vaishampayan-2 2024-03-26 monthly 0.7 https://oncdata.com/kidney-cancer-awareness-month-discovering-clinical-strategies-to-improve-outcomes-with-dr-samuel-kareff-dr-waqas-haque-and-dr-ulka-vaishampayan 2024-03-26 monthly 0.7 https://oncdata.com/mirvetuximab-soravtansine-gynx-approved-for-fra-positive-platinum-resistant-epithelial-ovarian-fallopian-tube-or-primary-peritoneal-cancer 2024-03-25 monthly 0.7 https://oncdata.com/multiple-myeloma-awareness-month-2024-what-patients-need-to-know 2024-03-25 monthly 0.7 https://oncdata.com/thirty-years-in-the-making-the-groundbreaking-approval-of-lifileucel-for-metastatic-melanoma-with-matthew-hadfield-do-and-richard-carvajal-md-2 2024-03-22 monthly 0.7 https://oncdata.com/discovering-research-advances-in-mesothelioma-with-samuel-kareff-md-mph-and-estela-rodriguez-md-mph-3 2024-03-21 monthly 0.7 https://oncdata.com/acquiring-expertise-for-improved-patient-outcomes-in-immune-thrombocytopenia 2024-03-20 monthly 0.7 https://oncdata.com/ponatinib-chemotherapy-granted-accelerated-approval-for-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia 2024-03-20 monthly 0.7 https://oncdata.com/rare-disease-day-2024-a-live-panel-discussion-with-dr-rahul-banerjee-matthew-hadfield-joseph-kalis-and-nagashree-seetharamu-2 2024-03-19 monthly 0.7 https://oncdata.com/emerging-technologies-in-therapeutics-and-diagnostics 2024-03-19 monthly 0.7 https://oncdata.com/garnering-knowledge-gains-for-treatment-of-advanced-renal-cell-carcinoma 2022-07-13 monthly 0.7